Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Common Equity (2016 - 2023)

Historic Common Equity for MediWound (MDWD) over the last 13 years, with Q2 2025 value amounting to $20.1 million.

  • MediWound's Common Equity rose 1259.16% to $20.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $20.1 million, marking a year-over-year increase of 1259.16%. This contributed to the annual value of $31.2 million for FY2024, which is 139.9% down from last year.
  • Latest data reveals that MediWound reported Common Equity of $20.1 million as of Q2 2025, which was up 1259.16% from $31.2 million recorded in Q4 2024.
  • In the past 5 years, MediWound's Common Equity ranged from a high of $34.9 million in Q2 2023 and a low of -$4.6 million during Q4 2021
  • Moreover, its 5-year median value for Common Equity was $10.9 million (2022), whereas its average is $13.6 million.
  • In the last 5 years, MediWound's Common Equity plummeted by 16300.88% in 2021 and then surged by 33819.29% in 2022.
  • Quarter analysis of 5 years shows MediWound's Common Equity stood at -$4.6 million in 2021, then surged by 338.19% to $10.9 million in 2022, then surged by 189.49% to $31.6 million in 2023, then decreased by 1.4% to $31.2 million in 2024, then tumbled by 35.42% to $20.1 million in 2025.
  • Its Common Equity stands at $20.1 million for Q2 2025, versus $31.2 million for Q4 2024 and $17.9 million for Q2 2024.